Estimating per-act HIV transmission risk: A systematic review

AIDS

Volumn 28, Issue 10, 2014, Pages 1509-1519

  Patel, Pragna ^a   Borkowf, Craig B ^a   Brooks, John T ^a   Lasry, Arielle ^a   Lansky, Amy ^a   Mermin, Jonathan ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

HIV; Per act; Prevention; Risk; Transmission

Indexed keywords

ANTIRETROVIRUS AGENT;

ANAL INTERCOURSE; ARTICLE; BLOOD TRANSFUSION; CIRCUMCISION; COITUS; CONDOM; DISEASE TRANSMISSION; EXPOSURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; META ANALYSIS; NEEDLESTICK INJURY; ORAL SEX; PRIORITY JOURNAL; RISK FACTOR; SEXUAL TRANSMISSION; SYSTEMATIC REVIEW; VERTICAL TRANSMISSION; IATROGENIC DISEASE; MOTHER CHILD RELATION; RISK ASSESSMENT; SEXUAL BEHAVIOR; TRANSMISSION;

DISEASE TRANSMISSION, INFECTIOUS; HIV INFECTIONS; HUMANS; IATROGENIC DISEASE; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MOTHER-CHILD RELATIONS; RISK ASSESSMENT; SEXUAL BEHAVIOR;

EID: 84902247495     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000298     Document Type: Article

References (80)

1. CDC. Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services. Morb Mortal Wkly Rep 2005; 54 (No.RR-2):1-20.
2. Varghese B, Maher JE, Peterman TA, Branson BM, Steketee RW. Reducing the risk of sexual HIV transmission: quantifying the per-act risk for HIV on the basis of choice of partner, sex act, and condom use. Sex Transm Dis 2002; 29:38-43.
3. Leynaert B, Downs AM, De Vincenzi I, European Study Group on Heterosexual Transmission of HIV. Heterosexual transmission of HIV: variability of infectivity throughout the course of infection. Am J Epidemiol 1998; 148:88-96.
4. European Study Group on Heterosexual Transmission of HIV. Comparison of female to male and male to female transmission of HIV in 563 stable couples. Br Med J 1992; 304:809-813.
5. Baggaley RF, Boily MC, White RG, Alary M. Risk of HIV-1 transmission for parental exposure and blood transfusion: a systematic review and meta-analysis. AIDS 2006; 20:805-812.
6. Baggaley RF, White RG, Boily MC. HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention. Int J Epidemiol 2010; 39:1048-1063.
7. Boily MC, Baggaley RF, Wang L, Masse B, White RG, Hayes RJ, Alary M. Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis 2009; 9:118-129.
8. Sperling RS, Shapiro DE, Coombs RW, Todd JA, Herman SA, McSherry GD, et al. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1996; 335:1621-1629.
9. Benn P, Fischer M, Kulasegaram R, BASSH, PEPSE Guidelines Writing Group Clinical Effectiveness Group. UK guideline for the use of post-exposure prophylaxis for HIV following sexual exposure (2011). Int J STD AIDS 2011; 22:695-708.
10. Kaplan EH, Heimer R. A model-based estimate of HIV infectivity via needle sharing. J Acquir Immune Defic Syndr 1992; 5:1116-1118.
11. Hudgens MG, Longini IM Jr, Choopanya K, Vanichseni S, Kitayaporn D, Mastro TD, et al. Estimating the transmission probability of human immunodeficiency virus in injecting drug users in Thailand. J R Stat Soc Ser C Appl Statist 2001; 50:1-14.
12. Hudgens MG, Longini IM Jr, Vanichseni S, Hu DJ, Kitayaporn D, Mock PA, et al. Subtype-specific transmission probabilities for human immunodeficiency virus type 1 among injecting drug users in Bangkok, Thailand. Am J Epidemiol 2002; 155:159-168.
13. Jin F, Jansson J, Law M, Prestage GP, Zablotska I, Imrie JCG, et al. Per-contact probability of HIV transmission in homosexual men in Sydney in the era of HAART. AIDS 2010; 24:907-913.
14. Vittinghoff V, Douglas J, Judson F, McKiman D, MacQueen K, Buchbinder S. Per-contact risk of human immunodeficiency virus transmission between male sexual partners. Am J Epidemiol 1999; 150:306-311.
15. DeGruttola V, Seage GR 3rd, Mayer KH, Horsburgh CR Jr. Infectiousness of HIV between male homosexual partners. J Clin Epidemiol 1989; 42:849-856.
16. Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al., Partners PrEP Study Team. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med 2012; 367:399-410.
17. Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Rose CE, Segolodi TM, et al., TDF2 Study Group. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med 2012; 367:423-434.
18. Weller SC, Davis-Beaty K. Condom effectiveness in reducing heterosexual HIV transmission (Review). Cochrane Database Syst Rev 2002. CD003255.
19. delRomano J, Marincovich B, Castilla J, Garcá S, Campo J, Hernando V, Rodríguez C. Evaluating the risk of HIV transmission through unprotected orogenital sex. AIDS 2002; 16:1296-1297.
20. Scott HM, Vittinghoff E, Irvin R, Sachdev D, Liu A, Gurwith M, Buchbinder SP. Age, race/ethnicity, and behavioral risk factors associated with per contact risk of HIV infection among men who have sex with men in the United States. J Acquir Immune Defic Syndr 2014; 65:115-121.
21. Ward JW, Bush TJ, Perkins HA, Lieb LE, Allen JR, Goldfinger D, et al. The natural history of transfusion-associated infection with human immunodeficiency virus. Factors influencing the rate of progression to disease. N Engl J Med 1989; 321:947-952.
22. Berglund O, Beckman S, Grillner L, Jansson B, Lidbrink P, Karlsson A, et al. HIV transmission by blood transfusion in Stockholm 1979-1985: nearly uniform transmission from infected donors. AIDS 1988; 2:51-54.
23. Colebunders R, Ryder R, Francis H, Nekwei W, Bahwe Y, Lebughe I, et al. Seroconversion rate, mortality, and clinical manifestations associated with the receipt of a human immunodeficiency virus-infected blood transfusion in Kinshasa, Zaire. J Infect Dis 1991; 164:450-456.
24. Donegan E, Lee TH, Operskalski EA, Shaw GM, Kleinman SH, Busch MP, et al. Transfusion transmission of retroviruses: human T-lymphotrophic virus types I and II compared with human immunodeficiency virus type 1. Transfusion 1994; 34:478-483.
25. Busch MP, Operskalski EA, Mosley JW, Lee TH, Henrard D, Herman S, et al. Factors influencing human immunodeficiency virus type 1 transmission by blood transfusion. Transfusion Safety Study Group. J Infect Dis 1996; 174:26-33.
26. Moore A, Herrera G, Nyamongo J, Lackritz E, Granade T, Nahlen B, et al. Estimated risk of HIV transmission by blood transfusion in Kenya. Lancet 2001; 358:657-660.
27. Donegan E, Stuart M, Niland JC, Sacks HS, Azen SP, Dietrich SL, et al. Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations. Ann Intern Med 1990; 113:733-739.
28. Weiss SH, Saxinger WC, Rechtman C, Grieco MH, Nadler J, Holman S, et al. HTLV-III infection among health care workers: association with needle-stick injuries. J Am Med Assoc 1985; 254:2089-2093.
29. Moss A, Osmond D, Bacchetti P, Gerberding J, Levy J, Carlson J, Casavant C. Risk of seroconversion for acquired immunodeficiency syndrome (AIDS) in San Francisco health workers. J Occup Med 1986; 28:821-824.
30. Kuhls TL, Viker S, Parris NB, Garakian A, Sullivan-Bolyai J, Cherry JD. Occupational risk of HIV, HBV and HSV-2 infections in health care personnel caring for AIDS patients. Am J Public Health 1987; 77:1306-1309.
31. Wormser GP, Joline C, Sivak SL, Arlin ZA. Human immunodeficiency virus infections: considerations for health care workers. Bull NY Acad Med 1988; 64:203-215.
32. Hernández E, Puyuelo T, Gatell JM, Barrera JM, Pumarola T. [Occupational risk of infection by human immunodeficiency virus]. Article in Spanish. Med Clin (Barc) 1988; 90:767-768.
33. Weiss SH, Goedert JJ, Gartner S, Popovic M, Waters D, Markham P, et al. Risk of human immunodeficiency virus (HIV-1) infection among laboratory workers. Science 1988; 239:68-71.
34. Strickler AC. Occupational exposure to HIV infection among health-care workers at the Toronto General Hospital. Can Dis Week Rep 1988; 14:141-146.
35. Jorbeck H, Steinkeller E. 41 cases of accidental infection with HIV-positive blood (in Swedish). Lakartidningen 1988; 85:3044-3045.
36. Jorbeck H, Marland M, Steinkeller E. Accidental exposures to HIV-positive blood among health-care workers in 2 Swedish hospitals. Fifth International Conference on AIDS, Montreal, Quebec, Canada; 1989 [Abstract A517].
37. Rogers PL, Lane HC, Henderson DK, Parrillo J, Masur H. Admission of AIDS patients to a medical intensive care unit: causes and outcome. Crit Care Med 1989; 17:113-117.
38. Puro V, Ranchino M, Profili F. Occupational exposures to blood and risk of HIV transmission in a general hospital (1986-88). Eur J Epidemiol 1990; 6:67-70.
39. Henderson DK, Fahey BJ, Willy M, Schmitt JM, Carey K, Koziol DE, et al. Risk for occupational transmission of human immunodeficiency virus type 1 (HIV-1) associated with clinical exposures. A prospective evaluation. Ann Intern Med 1990; 113:740-746.
40. McCormick RD, Meisch MG, Ircink FG, Maki DG. Epidemiology of hospital sharps injuries: a 14-year prospective study in the pre-AIDS and AIDS eras. Am J Med 1991; 91:301S-307S
41. National surveillance of occupational exposure to the human immunodeficiency virus (HIV). Can Commun Dis Rep 1992; 18:103-104.
42. Cavalcante NJ, Abreu ES, Fernandes ME, Richtmann R, Piovesana MN, Yamada FT, Carvalho ES. Risk of healthcare professionals acquiring HIV infection in Latin America. AIDS Care 1991; 3:311-316.
43. Cavalcante NJ, Richtmann R, Abreu ES, Ramalho MO, Piovesana MN, Carvalho ES. Changing of notifications of accidents with HIV infective materials, among healthcare professionals (HCP) at Emilio Ribas Institute, Sao Paolo, Brazil. IX International Conference on AIDS, Berlin, June 1993 [abstract PO-C18- 3030].
44. Ippolito G, Puro V, De Carli G. The risk of occupational human immunodeficiency virus infection in healthcare workers. Italian Multicenter Study. The Italian Study Group on Occupational Risk of HIV Infection. Arch Intern Med 1993; 153:1451-1458.
45. Ippolito G, De Carli G, Puro V, Petrosillo N (SIROH). SIROdH. Risk of occupational HIV and HCV infection after occupational exposure. XI International Conference on AIDS, Vancouver, July 1996 [abstract TuC123].
46. Tokars JI, Marcus R, Culver DH, Schable CA, McKibben PS, Bandea CI, Bell DM. Surveillance of HIV infection and zidovudine use among healthcare workers after occupational exposure to HIV-infected blood. The CDC Cooperative Needlestick Surveillance Group. Ann Intern Med 1993; 118:913-919.
47. Cardo D, Tokars J, Marcus R, McKibben P, Culver D, Ciesielski C, Bell D, Cooperative Needlestick Group. Zidovudine (AZT) use after occupational HIV exposure: toxicity and failures reported to CDC; an update [Abstract]. Conference on Prevention of Transmission of Bloodborne Pathogens in Surgery and Obstetrics, Atlanta. Infect Control Hosp Epidemiol 1994; 15:342.
48. Communidad de Madrid CdS. Registro de inoculaciones accidentales (VIH) en personal sanitario de la CAM. Vigilancia Epidemiologica del SIDA/VIH 1993; 12:65-72.
49. de Juanes JR, Lago E, Davila F, Aragon AJ, Arrazola P, Garcia Codes A, et al. Injuries with exposure to blood in surgeons of a university hospital, over a year period. Abstract. Conference on prevention of transmission of bloodborne pathogens in surgery and obstetrics, Atlanta. Infect Control Hosp Epidemiol 1994; 15:343.
50. Nelsing S, Nielsen TL, Nielsen JO. Occupational exposure to human immunodeficiency virus among healthcare workers in a Danish hospital. J Infect Dis 1994; 169:478.
51. Gerberding JL. Incidence and prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and cytomegalovirus among health care personnel at risk for blood exposure: final report from a longitudinal study. J Infect Dis 1994; 170:1410-1417.
52. Jost J, Iten A, Meylan P, Columbo C, Maziero A. Mise a jour sur les expositions au VIH en milieu medical. Mesures generales, chimioprophylaxie, declaration. Bull Office Fed Sante Pub 1997; 7:5-12.
53. PHLS. Occupational exposures associated with HIV infection in healthcare workers: update to Sept 97. PHLS AIDS and STD Centre & Scottish Centre for Infection and Environmental Health
54. Halperin DT, Shiboski SC, Palefsky SC, Padian NS. High level of HIV-1 infection from anal intercourse: a neglected risk factor in heterosexual AIDS prevention. Int Conf AIDS 7-12 July 2002, 14 [abstract ThPeC7438]
55. Kim HC, Raska K III, Clemow L, Eisele J, Maits L, Saidi P, Raska K Jr. Human immunodeficiency virus infection in sexually active wives of infected hemophilic men. Am J Med 1988; 85:472-476.
56. Longini IM, Scott Clark W, Haber M, Horsburgh R Jr. The stages of HIV infection: waiting times and infection transmission probabilities. In: Castillo-Chavez C. editor. Mathematical and statistical approaches to AIDS epidemiology Berlin: Springer- Verlag; 1989. pp. 111-137.
57. Brooks Jackson J, Kwok SY, Hopsicker JS, Sannerud KJ, Sninsky JJ, Edson R, Ballour HH Jr. Absence of HIV-1 infection in antibody-negative sexual partners of HIV-1 infected hemophiliacs. Transfusion 1989; 29:265-267.
58. Lawrence DN, Jason JM, Holman RC, Heine P, Evatt BL. Sex practice correlates of human immunodeficiency virus transmission and acquired immunodeficiency syndrome incidence in heterosexual partners and offspring of U.S. hemophilic men. Am J Hematol 1989; 30:68-76.
59. Kim MY, Lagakos SW. Estimating the infectivity of HIV from partner studies. Ann Epidemiol 1990; 1:117-128.
60. Downs AM, De Vincenzi I. Probability of heterosexual transmission of HIV: relationship to the number of unprotected sexual contacts. European Study Group in Heterosexual Transmission of HIV. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 11:388-395.
61. Marincovich B, Castilla J, del Romero J, Garcá S, Hernando V, Raposo M, Rodríguez C. Absence of hepatitis C virus transmission in a prospective cohort of heterosexual serodiscordant couples. Sex Transm Infect 2003; 79:160-162.
62. Padian NS, Shiboski SC, Glass SO, Vittinghoff E. Heterosexual transmission of human immunodeficiency virus (HIV) in northern California: results from a ten-year study. Am J Epidemiol 1997; 146:350-357.
63. Shiboski SC, Padian NS. Epidemiologic evidence for time variation in HIV infectivity. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 19:527-535.
64. Saracco A, Veglia F, Lazzarin A. Risk of HIV-1 transmission in heterosexual stable and random couples. The Italian Partner Study. J Biol Regul Homeost Agents 1997; 11:3-6.
65. Campo J, Perea MA, del Romano J, Cano J, Hernando V, Bascones A. Oral transmission of HIV, reality or fiction An update. Oral Dis 2006; 12:219-228.
66. Raiteri R, Baussano I, Giobbia M, Fora R, Sinicco A. Lesbian sex and risk of HIV transmission. AIDS 1998; 12:450-451.
67. Baggaley RF, White RG, Boily MC. Systematic review of orogenital HIV-1 transmission probabilities. Int J Epidemiol 2008; 37:1255-1265.
68. Siegfried N, van der Merwe L, Brocklehurst P, Sint TT. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection (Review). Cochrane Database of Systematic Reviews 2011. CD003510.
69. Hughes JP, Baeten JM, Lingappa JR, Magaret AS, Wald A, de Bruyn G, et al., Partners in Prevention HSV/HIV Transmission Study Team. Determinants of per-coital HIV-1 infectivity among African HIV-1-serodiscordant couples. J Infect Dis 2012; 205:358-365.
70. Wawer MJ, Gray RH, Sewankambo NK, Serwadda D, Li X, Laeyendecker O, et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 2005; 191:1403-1409.
71. Hollingsworth TD, Anderson RM, Fraser C. HIV-1 transmission, by stage of infection. J Infect Dis 2008; 198:687-693.
72. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al., HPTN 052 Study Team. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365:493-505.
73. Donnell D, Baeten JM, Klarie J, Thomas KK, Stevens W, Cohen CR, et al., Partners in Prevention HSV/HIV Transmission Study Team. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet 2010; 375:2092-2098.
74. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al., iPrEx Study Team. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010; 363:2587-2599.
75. Sigfried N, Muller M, Deeks JJ, Volmink J. Male circumcision for prevention of heterosexual acquisition of HIV in men (Review). Cochrane Database Syst Rev 2009CD003362.
76. Weiss HA, Hankins CA, Dickson K. Male circumcision and risk of HIV infection in women: a systematic review and meta-analysis. Lancet Infect Dis 2009; 9:669-677.
77. Wiysonge CS, Kongnyuy EJ, Shey M, Muula AS, Navti OB, Akl EA, Lo YR. Male circumcision for prevention of homosexual acquisition of HIV in men (Review). Cochrane Database Syst Rev 2011CD007496.
78. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med 2005; 2:e298.
79. Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomized controlled trial. Lancet 2007; 369:643-656.
80. Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomized trial. Lancet 2007; 369:657-666.